Whole slide imaging paired with AI-driven analysis, across our 5 wet-laboratory locations.
Digital Pathology & Image Analysis
As a pioneer in digital pathology, NeoGenomics combines whole-slide imaging with AI-driven analysis to deliver actionable, life-saving insights faster. We empower pathologists to deliver precise diagnoses by streamlining workflows and driving standardization through our expanding suite of computational pathology tools—ultimately guiding critical treatment decisions.
Source description, from Indica Labs: the HALP Breast IHC AI Suite performs automated carcinoma in situ classification and control tissue removal prior to biomarker scoring, delivering guideline-aligned quantification of HER2, ER, PR, and Ki67 in invasive breast cancer. Attribution and regulatory line to be supplied by Marketing and Regulatory. Imagery courtesy of Indica Labs.
Image Analysis
Semi-quantitative image analysis is available for the following biomarkers.
- ER
- PR
- Ki-67
- HER2
- MMR
- Additional markers currently being evaluated
Whole Slide Imaging
A fleet of Leica whole slide scanners digitizes solid tumor histology slides across our 5 wet-laboratory locations
| Whole Slide Imaging | Leica AT2, GT450, and GT180 |
|---|---|
| Locations | 5 wet-laboratory locations |
| Slides | Solid tumor histology |
Platform & Partnership
Expanded partnership with Indica Labs
We have expanded our partnership with Indica Labs to integrate the Halo AP® Platform on a scalable, cloud-based framework. The modernized system lets us add third-party or in-house AI tools without major disruption.
Read the press release